Proteinea
Founded 2020 · 51 employees on LinkedIn · 5 known investors
Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.
Founders & leadership
AE
Abdulaziz Elgammal
ME
Mahmoud Eljendy
Investors · 5
Frequently asked questions
- What does Proteinea do?
- Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.
- Who are Proteinea's investors?
- Proteinea's investors include 500 Global, Sadu Capital, Sawari Ventures, Shorooq Partners, VentureSouq.